Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Somatostatin Analogs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidence of Cushing Syndrome, Acromegaly and Other Associated Diseases
5.1.1.2. Extensive Spending on Development of Drugs for Rare Diseases Globally
5.1.1.3. Favorable Government Policies and Schemes for Patients with Rare Diseases
5.1.2. Restraints
5.1.2.1. Reduced Awareness Resulting in a High Number of Undiagnosed Patients
5.1.3. Opportunities
5.1.3.1. Ongoing Research and Development Activities for the Launch of Novel Drug Therapeutics
5.1.3.2. Strategic Collaboration Among Pharmaceutical and Research Companies
5.1.4. Challenges
5.1.4.1. Availability of Alternative Treatment Methods for Diseases Such as Acromegaly
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Somatostatin Analogs Market, by Type
6.1. Introduction
6.2. Lanreotide
6.3. Octreotide
6.4. Pasireotide

7. Somatostatin Analogs Market, by Application
7.1. Introduction
7.2. Acromegaly
7.3. Neuroendocrine Tumors

8. Americas Somatostatin Analogs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Somatostatin Analogs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Somatostatin Analogs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbiotec, Inc.
12.1.2. Advanz Pharma Corp.
12.1.3. Amryt Pharma PLC
12.1.4. Bachem AG
12.1.5. Biodexa Pharmaceuticals PLC
12.1.6. Camurus AB
12.1.7. Cipla Limited
12.1.8. Crinetics Pharmaceuticals, Inc.
12.1.9. CVS Health Corporation
12.1.10. Dauntless Pharmaceuticals, Inc.
12.1.11. Fresenius SE & Co. KGaA
12.1.12. Hybio Pharmaceutical Co., Ltd.
12.1.13. Ipsen Pharma
12.1.14. MedKoo Biosciences, Inc.
12.1.15. Merck KGaA
12.1.16. Novartis AG
12.1.17. Peptron, Inc.
12.1.18. Pfizer Inc.
12.1.19. Pharmascience Inc.
12.1.20. Recordati Rare Diseases, Inc.
12.1.21. Sun Pharmaceutical Industries Limited
12.1.22. Teijin Limited
12.1.23. Teva Pharmaceuticals Inc.
12.1.24. Viatris Inc.
12.1.25. Wockhardt Ltd.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. SOMATOSTATIN ANALOGS MARKET RESEARCH PROCESS
FIGURE 2. SOMATOSTATIN ANALOGS MARKET SIZE, 2022 VS 2030
FIGURE 3. SOMATOSTATIN ANALOGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SOMATOSTATIN ANALOGS MARKET DYNAMICS
FIGURE 7. SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. SOMATOSTATIN ANALOGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. SOMATOSTATIN ANALOGS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. SOMATOSTATIN ANALOGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. SOMATOSTATIN ANALOGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. SOMATOSTATIN ANALOGS MARKET SIZE, BY LANREOTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SOMATOSTATIN ANALOGS MARKET SIZE, BY OCTREOTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SOMATOSTATIN ANALOGS MARKET SIZE, BY PASIREOTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. SOMATOSTATIN ANALOGS MARKET SIZE, BY ACROMEGALY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SOMATOSTATIN ANALOGS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. CANADA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. CANADA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. MEXICO SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. MEXICO SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CHINA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. CHINA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. INDIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. INDIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. JAPAN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. JAPAN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. THAILAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. THAILAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. DENMARK SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EGYPT SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. EGYPT SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FINLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. FINLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. FRANCE SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ITALY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NORWAY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. NORWAY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. POLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. POLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. QATAR SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SPAIN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TURKEY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. TURKEY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. SOMATOSTATIN ANALOGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 99. SOMATOSTATIN ANALOGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 100. SOMATOSTATIN ANALOGS MARKET LICENSE & PRICING